CRT 2026
Valve and Structural
Vinod Thourani, MD, FACC, FACS
Professor of Surgery, Chairman of Cardiovascular Surgery
Piedmont Heart Institute
Atlanta, Georgia, United States
Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); JenaValve Technology Inc: Grant/Research Support (Ongoing); Laplace: Grant/Research Support (Ongoing); Trisol: Stock Options [in privately held companies] (Ongoing)
Vinod Thourani, MD, FACC, FACS
Professor of Surgery, Chairman of Cardiovascular Surgery
Piedmont Heart Institute
Atlanta, Georgia, United States
Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); JenaValve Technology Inc: Grant/Research Support (Ongoing); Laplace: Grant/Research Support (Ongoing); Trisol: Stock Options [in privately held companies] (Ongoing)